文献速递脑血管病

他汀与既往缺血性卒中或TIA患者脑出血风险

Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack.
PubMed 文献 · Stroke · 2017-10-25

基于英国初级保健数据库的人群队列研究,纳入有缺血性卒中或TIA病史的157例脑出血患者和884例对照,评估入院前他汀使用与脑出血风险的关系。结果显示他汀使用与总体脑出血风险、30天致死性或非致死性脑出血均无显著关联。

要点

  • 既往IS/TIA患者中,他汀使用未增加脑出血风险。
  • 近期使用他汀与总体脑出血风险无显著关联。
  • 致死性和非致死性脑出血30天发生率无差异。

核心结论

  • 在既往有IS或TIA病史的患者中,他汀使用与脑出血风险增加无关。

研究设计与样本

  • 基于英国健康改善网络初级保健数据库的人群队列研究,识别低剂量阿司匹林新使用者及匹配对照。
  • 嵌套病例对照分析纳入157例脑出血患者和884例有IS/TIA病史的对照。

主要发现

  • 脑出血前1年内末次他汀使用OR为0.92(95%CI 0.60-1.4)。
  • 末次使用在8天至1年间OR为1.81(95%CI 0.99-3.28)。
  • 脑出血时他汀使用OR为0.77(95%CI 0.49-1.21)。
  • 30天致死性脑出血OR为0.82(95%CI 0.41-1.64),非致死性OR为0.90(95%CI 0.51-1.57)。

临床怎么用

  • 对有IS或TIA病史的患者,他汀使用无需因脑出血风险顾虑而调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Although there is no overall association between statin use and intracerebral hemorrhage (ICH), whether there is an increased risk among those with a history of ischemic stroke (IS) or transient ischemic attack (TIA) remains controversial. We evaluated the relationship of preadmission statin use with the risk of ICH in patients with a history of IS or TIA in a population-based cohort. METHODS: The Health Improvement Network primary care database in the United Kingdom was used to identify new users of low-dose aspirin and a matched comparison. Both cohorts were followed to identify incident cases of ICH, with validation by manual review of patient records and linkage to hospitalization data. In a nested case-control study, we compared the adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for ICH based on statin use in the subgroup of individuals with history of IS/TIA. RESULTS: Last statin use within 1 year of ICH (OR, 0.92; 95% CI [confidence interval], 0.60-1.4), last use between 8 days and 1 year (OR, 1.81; 95% CI, 0.99-3.28), and statin use at the time of ICH (OR, 0.77; 95% CI, 0.49-1.21) were not associated with the overall ICH risk among 157 patients with ICH and 884 controls with a history of IS/TIA. There was also no difference in 30-day rates of fatal (OR, 0.82; 95% CI, 0.41-1.64) or nonfatal (OR, 0.90; 95% CI, 0.51-1.57) ICH. CONCLUSIONS: Statin use was not associated with an increased risk of ICH among patients with a previous history of IS/TIA.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gaist D, Goldstein LB, Cea Soriano L, et al. Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. Stroke. 2017. PMID: 29070714. doi:10.1161/STROKEAHA.117.019141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。